Published in Am J Pathol on November 01, 1990
Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol (1993) 1.43
Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma. J Korean Med Sci (2005) 1.19
Classical Hodgkin's disease. Clinical impact of the immunophenotype. Am J Pathol (1997) 1.08
The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol (1997) 1.06
PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus. Mod Pathol (2010) 1.06
Immunotherapy targets in pediatric cancer. Front Oncol (2012) 0.97
Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. Am J Pathol (1994) 0.93
Inconsistency of the immunophenotype of Reed-Sternberg cells in simultaneous and consecutive specimens from the same patients. A paraffin section evaluation in 56 patients. Am J Pathol (1992) 0.90
MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. J Clin Pathol (2001) 0.85
T-cell lymphomas, a challenging disease: types, treatments, and future. Int J Clin Oncol (2016) 0.75
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48
Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood (1989) 2.95
Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. Am J Clin Pathol (1984) 2.65
Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathology (1989) 2.40
Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy? Am J Surg Pathol (1988) 2.31
Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease. Cancer Res (1971) 1.94
BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood (1989) 1.76
Observer disagreement in the classification and histology of Hodgkin's disease. J Natl Cancer Inst (1970) 1.49
Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel. Am J Surg Pathol (1988) 1.35
Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol (1988) 1.33
Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood (1986) 1.27
Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol (1988) 1.21
Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol (1988) 1.21
Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol (1990) 1.20
A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol (1989) 1.18
Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol (1986) 1.17
Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded tissues: II. Profiles of reactivity in the various tumour types. Histopathology (1989) 1.13
Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease. Am J Pathol (1988) 1.11
Analysis of the Rye classification of Hodgkin's disease. The prognostic significance of cellular composition. J Natl Cancer Inst (1973) 1.09
A quantitative study of eosinophil polymorphs in Hodgkin's disease. J Clin Pathol (1984) 1.01
The elusive Reed-Sternberg cell. N Engl J Med (1989) 0.89
Large-cell hematolymphoid neoplasms of uncertain lineage. Hum Pathol (1988) 0.89
Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease. Virchows Arch A Pathol Anat Histopathol (1990) 0.88
Hodgkin's disease: a flow cytometric study. J Clin Pathol (1988) 0.83
Involution patterns of the human thymus. I Size of the cortical area as a function of age. Clin Exp Immunol (1982) 0.81
Hodgkin's disease. Histopathology (1987) 0.78
Histogenesis of Hodgkin's disease: possible insights from a comparison with lymphomatoid papulosis. Hum Pathol (1987) 0.78
Pathology of Hodgkin's disease. Some unresolved problems. Hematol Pathol (1988) 0.77
[Differentiation pathways of normal and malignant cells of the lymphatic system]. Verh Dtsch Ges Pathol (1988) 0.77
The Sternberg-Reed cell: mononuclear, multinucleated or multilobated? Virchows Arch A Pathol Anat Histol (1980) 0.77
Immunopathological lymph node findings in Hodgkin's disease: correlation to survival. Res Exp Med (Berl) (1975) 0.77
Mantle zone lymphoma: a morphometric comparison with centrocytic and immunocytic lymphomas and reactive secondary follicles. Hum Pathol (1988) 0.77
Comments on Hodgkin's disease: the Sternberg-Reed cell by P. Bucsky. Blut (1988) 0.77
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell (1997) 6.28
Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol (1993) 6.15
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature (1999) 5.76
Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med (1995) 4.51
Two different subunits of importin cooperate to recognize nuclear localization signals and bind them to the nuclear envelope. Curr Biol (1995) 4.46
Nonspecific acid esterase activity: a criterion for differentiation of T and B lymphocytes in mouse lymph nodes. Eur J Immunol (1975) 4.16
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood (2000) 3.99
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood (2000) 3.13
Digital dermoscopy analysis for the differentiation of atypical nevi and early melanoma: a new quantitative semiology. Arch Dermatol (1999) 2.85
Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A (1991) 2.82
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood (1995) 2.67
Importin provides a link between nuclear protein import and U snRNA export. Cell (1996) 2.65
Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med (1997) 2.59
The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol (1998) 2.44
A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J (1998) 2.43
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J (2001) 2.41
ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood (1998) 2.41
Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood (1990) 2.40
ALK+ lymphoma: clinico-pathological findings and outcome. Blood (1999) 2.38
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia (2009) 2.28
The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol (1999) 2.22
Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol (1982) 2.22
Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes. EMBO J (2000) 2.18
Re-assessment of Boyden's technique for measuring chemotaxis. J Immunol Methods (1972) 2.05
A tetrameric complex of membrane proteins in the endoplasmic reticulum. Eur J Biochem (1993) 2.04
Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol (1995) 2.03
Importin 13: a novel mediator of nuclear import and export. EMBO J (2001) 1.98
Malignant cells are collected on circular staplers. Dis Colon Rectum (1992) 1.94
Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J Immunol (1989) 1.89
PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol (1993) 1.81
BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood (1989) 1.76
Specific antibody within lymphoid germinal center cells of mice after primary immunization with horseradish peroxidase: a light and electron microscopic study. J Exp Med (1970) 1.75
Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis (1997) 1.74
Autonomic dysfunction in Parkinson's disease. Neurol Sci (2003) 1.69
HIV-associated malignant lymphomas in Kenya (Equatorial Africa) Hum Pathol (1998) 1.66
Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood (1993) 1.63
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Ann Oncol (2009) 1.62
MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. J Biol Chem (1999) 1.58
Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Int J Tuberc Lung Dis (2009) 1.57
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. Leukemia (2009) 1.56
Prenatal diagnosis and outcome of echogenic fetal lung lesions. Ultrasound Obstet Gynecol (2008) 1.56
Studies on the regulation of the neutrophil chemotactic response using a rapid and reliable method for measuring random migration and chemotaxis of neutrophil granulocytes. Agents Actions (1976) 1.54
Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int J Cancer (1991) 1.53
Analysis of mammalian 20S proteasome biogenesis: the maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J (1996) 1.53
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol (2008) 1.52
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51
Novel genes coding for lithotrophic sulfur oxidation of Paracoccus pantotrophus GB17. J Bacteriol (2000) 1.47
Mammalian Sec61 is associated with Sec62 and Sec63. J Biol Chem (2000) 1.47
Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. J Mol Biol (1989) 1.46
Immunomodulation by intravenous immunoglobulin. Am J Pediatr Hematol Oncol (1990) 1.46
Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. J Immunol (2000) 1.44
Rett syndrome and plasma leptin levels. J Pediatr (2007) 1.44
CSF levels of beta-amyloid 1-42, tau and phosphorylated tau protein in CADASIL. Eur J Neurol (2008) 1.44
Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol (1993) 1.43
MR-defecography in obstructed defecation syndrome (ODS): technique, diagnostic criteria and grading. Tech Coloproctol (2013) 1.42
Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications. Br J Haematol (1994) 1.40
Incorporation of major histocompatibility complex--encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-gamma. Eur J Immunol (1995) 1.40
Late results in patients treated with pi-mesons for bladder cancer. Cancer (1993) 1.39
Tubuloreticular inclusions and viral particles in a case of hairy cell leukemia. Haematologica (1989) 1.39
Variability of proliferative patterns in acute lymphoid leukemia of children. Blood (1972) 1.37
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia (2007) 1.36
A third interferon-gamma-induced subunit exchange in the 20S proteasome. Eur J Immunol (1996) 1.35
The signal sequence receptor has a second subunit and is part of a translocation complex in the endoplasmic reticulum as probed by bifunctional reagents. J Cell Biol (1990) 1.35
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35
Physiology of chemotaxis and random motility. Semin Hematol (1975) 1.35
Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant). Brain Dev (2008) 1.34
Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet (1987) 1.34
The growth-related protein P23 of the Ehrlich ascites tumor: translational control, cloning and primary structure. Biochem Int (1989) 1.33
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. Leuk Res (1989) 1.31
Molecular cloning, sequencing and expression in Escherichia coli of the 25-kDa growth-related protein of Ehrlich ascites tumor and its homology to mammalian stress proteins. Eur J Biochem (1989) 1.31
Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression. J Pathol (1996) 1.30
A proposal for a standardized system of reporting human lymph node morphology in relation to immunological function. J Clin Pathol (1973) 1.29
Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol (1994) 1.29
Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes). Histopathology (1990) 1.24
Histological and immunohistological analysis of human lymphomas. Crit Rev Oncol Hematol (1989) 1.22
Early and enhanced germinal center formation and antibody responses in mice after primary stimulation with antigen-isologous antibody complexes as compared with antigen alone. J Immunol (1971) 1.20
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. Ann Oncol (2009) 1.20
The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses. J Immunol (2000) 1.20